Can Exercise Slow Cognitive Decline? A New Look at Diabetes and Brain Health
"A pilot study explores how a multi-modal exercise program could boost cognitive function in older adults with Type 2 diabetes, offering hope for preventing dementia."
The global rise in dementia cases is a growing concern, with projections estimating nearly 115 million affected individuals by 2050. As the search for effective disease-modifying medications continues, identifying preventive strategies, particularly for high-risk individuals, has become crucial. Type 2 diabetes (T2D) has emerged as a significant modifiable risk factor, increasing the risk of dementia nearly twofold.
Individuals with T2D often experience accelerated cognitive decline, predominantly affecting executive function and processing speed. This decline is attributed to a mix of neurodegeneration and cerebrovascular disease. Given the complex interplay of risk factors associated with T2D-related dementia, therapeutic approaches addressing multiple factors simultaneously are likely to yield the best outcomes. Structured exercise training has shown promise, improving glycemic, metabolic, and vascular profiles in individuals with T2D.
While observational studies suggest exercise benefits cognitive health, randomized controlled trials (RCTs) in older adults have produced inconsistent results. People with T2D represent a unique high-risk group with clustered biological risk factors for cognitive decline, making them potentially responsive to risk factor optimization through multi-modal exercise programs. A pilot RCT was conducted to assess the feasibility and potential cognitive benefits of a multi-modal exercise program.
Why Brain Health Matters in Diabetes
Type 2 diabetes and cognitive decline are increasingly discussed as overlapping health concerns. The relationship appears complex and may involve several contributing factors rather than a single cause. Understanding this connection is important because cognitive changes can affect everyday health decisions and diabetes self-management.
Current Methods and Their Limits
Current approaches include managing diabetes while assessing cognitive function through cognitive evaluations and, when appropriate, neuroimaging techniques such as magnetic resonance imaging and positron emission tomography. Reviews describe links between diabetes and a range of outcomes, from mild cognitive impairment to vascular and Alzheimer dementia, but clinical guidance for addressing cognitive dysfunction has only recently developed. A meta-analysis found that intensive glycaemic control was not associated with either increased or decreased cognitive decline compared with standard glycaemic control in patients with type 2 diabetes, while diagnostic tools can have limitations in detecting early-stage decline.
From Association to a Broader Framework
Earlier research established an association between type 2 diabetes and cognitive status, but the CDC-hosted study specifically cautioned that it did not demonstrate a causal relationship between type 2 diabetes and impaired cognition. Later literature recognized that diabetes may contribute to both vascular and neurodegenerative dementia syndromes, particularly when hypertension is also present. Research has also described different stages of diabetes-associated cognitive dysfunction, with potentially different cognitive features, age groups, prognoses, and underlying mechanisms.
The CDOT-X Study: Design and Multi-Modal Exercise
The Cognition and Diabetes in Older Tasmanians A pilot RCT of exercise (CDOT-X) study was a 6-month single-blind parallel RCT. It compared a progressive multi-modal exercise program with a stretching and gentle movement control group. The study included individuals with previously diagnosed T2D, and outcome assessments were blinded. The exercise program included aerobic and resistance training (ART).
- Aerobic and Resistance Training (ART): This program involved two supervised one-hour sessions per week, supplemented by one unsupervised session at home. It consisted of approximately 30 minutes of moderate- to high-intensity progressive resistance training (PRT) and 30 minutes of aerobic activity like cycling or treadmill walking. The intensity was individually tailored and progressed based on the Borg Scale of perceived exertion.
- Control Intervention: Participants in this group received a 6-month light intensity stretching and gentle movement program, also implemented by accredited exercise physiologists. This included two supervised one-hour sessions per week and one unsupervised session at home. The activities were designed to match the participative involvement and socialization of the intervention group.
What Recent Research Is Examining
Recent reviews continue to treat the relationship between type 2 diabetes and cognitive impairment as a significant public health concern, especially as diabetes prevalence rises globally and populations age. A 2025 review examined the association between type 2 diabetes mellitus and cognitive impairment, while another 2025 study reviewed evidence on factors affecting cognitive decline in people with type 2 diabetes. A separate cross-sectional study of adults aged 18 years and older with type 2 diabetes investigated risk factors for cognitive impairment using demographic and laboratory information.
Why the Evidence Is Not Simple
The available reviews describe cognitive impairment in type 2 diabetes as a broad problem affecting multiple cognitive domains, with possible progression to dementia. They also emphasize that cognitive impairment can complicate daily life and blood-glucose management, potentially worsening treatment and prognosis. These findings support concern about the association, but they do not by themselves establish that every case follows the same course or that one intervention will prevent decline.
Interpreting Different Approaches
Comparisons between approaches to diabetes and cognitive health should account for differences in study design, participant characteristics, and the cognitive outcomes being measured. The evidence base includes broad reviews as well as studies focused on specific risk factors, so their conclusions may address different questions. For that reason, current findings are better viewed as complementary evidence than as a definitive ranking of one strategy over another.
The Path Forward
This pilot study provides encouraging evidence for the feasibility and potential benefits of a multi-modal exercise program in preserving cognitive function among individuals with T2D. Further research is needed to confirm these findings and determine the long-term impact of exercise on cognitive health.
A Cautious Synthesis
The evidence supports taking cognitive health seriously in people with type 2 diabetes while recognizing that the relationship is multifactorial. Existing research connects diabetes with cognitive impairment, but important questions remain about causation, prevention, and which interventions are most effective. A balanced interpretation therefore combines diabetes care with attention to cognitive changes rather than treating glycaemic control alone as a guaranteed solution.
Where Research May Go Next
Future research is likely to focus on identifying cognitive decline earlier and clarifying which people with type 2 diabetes face the greatest risk. Progress will require studies that connect cognitive assessments with diabetes-related clinical factors over time. The key unanswered question is whether cognitive decline associated with type 2 diabetes can be meaningfully modified.
A Multisystem Challenge
Type 2 diabetes is increasingly associated with cognitive impairment and dementia through a combination of metabolic dysregulation, vascular injury, neuroinflammation, and defective brain insulin signaling. Although this link is now widely recognized, it remains unclear whether cognitive decline in type 2 diabetes is modifiable. This uncertainty highlights the need for systemic approaches that address both metabolic and neurological health.
Living With Both Conditions
The prevalence of type 2 diabetes and cognitive dysfunction increases with age, meaning clinicians will increasingly care for older people managing both conditions. Cognitive dysfunction can affect diabetes self-management and may complicate clinical decision-making. Research has identified potentially preventable or improvable risk factors, but real-world care still requires attention to the individual’s age, cognitive status, and diabetes needs.